OnKure Therapeutics, Inc. (OMUR)
NGM · Common · CUSIP 68277Q105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for OMUR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68277Q105
Previous Symbol
RPHM (changed 10/2/2024)
Previous Name
Reneo Pharmaceuticals, Inc
Business: OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company Using a structure- and computational chemistry-driven drug design platform focused on discovering and developing precision medicines that target biologically validated drivers of diseases underserved by available therapies.

Company Contact

CEO
Nicholas A. Saccomano
CFO
Jason Leverone
Headquarters
6707 Winchester Circle, #400, Boulder, CO 80201
Phone
720-307-2892
Investor Relations
Dan Ferry, LifeSci Advisors · 617-430-7576 · daniel@lifesciadvisors.com
SEC EDGAR Filings
View filings »